We found that an extra-abdominal primary site, lower stage (stage 1/2), MYCN non-amplified tumor, and low-risk group categorization were associated with a longer germline telomere length (P = 0.015, 0.007, 0.046, and 0.042, respectively). This evidence concerns the gene MYCN and neoplasm.